AJU IB Investment Co., Ltd. Long-Term Concentrated

Location: Seoul, Korea, Republic of

CIK: 0001710065 · Show all filings

Period: Q3 2022 (← Previous) (Next →)

Filing Date: Nov 14, 2022

Total Value: $58.42M (100.0% shares, 0.0% debt)

Holdings (7)

ACLX ARCELLX INC 44.4%

Value $25.92M Shares 1,380,890 Est. Cost $16.72 Unrealized +14.4%

— RALLYBIO CORP 18.7%

Value $10.92M Shares 754,678 Est. Cost $9.54 Unrealized —

KYMR KYMERA THERAPEUTICS INC 17.0%

Value $9.95M Shares 457,059 Est. Cost $48.78 Unrealized -46.0%

SEER SEER INC 10.8%

Value $6.319M Shares 816,375 Est. Cost $63.62 Unrealized -84.7%

— RAPT THERAPEUTICS INC 4.1%

Value $2.394M Shares 99,503 Est. Cost $19.75 Unrealized —

XLO XILIO THERAPEUTICS INC 3.3%

Value $1.943M Shares 667,742 Est. Cost $17.03 Unrealized -83.7%

— SUTRO BIOPHARMA INC 1.7%

Value $971K Shares 175,000 Est. Cost $21.71 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ACLX	ARCELLX INC	1,380,890	$25.92M	44.4%	$16.72	+14.4%	COMMON STOCK	03940C100
—	RALLYBIO CORP	754,678	$10.92M	18.7%	$9.54	—	COM	75120L100
KYMR	KYMERA THERAPEUTICS INC	457,059	$9.95M	17.0%	$48.78	-46.0%	COM	501575104
SEER	SEER INC	816,375	$6.319M	10.8%	$63.62	-84.7%	COM CL A	81578P106
—	RAPT THERAPEUTICS INC	99,503	$2.394M	4.1%	$19.75	—	COM	75382E109
XLO	XILIO THERAPEUTICS INC	667,742	$1.943M	3.3%	$17.03	-83.7%	COM	98422T100
—	SUTRO BIOPHARMA INC	175,000	$971K	1.7%	$21.71	—	COM	869367102